Click for best price
Invitro Diagnostic Services Market Size, Share 2024
| Market size in 2023 |
US$ 60800 million
|
Forecast Market size by 2030 |
US$ 83090 million
|
| Growth Rate |
CAGR of 4.5% |
Number of Pages |
109 Pages |
This research report provides a comprehensive analysis of the In-vitro Diagnostic Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global In-vitro Diagnostic Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of In-vitro Diagnostic Services, challenges faced by the industry, and potential opportunities for market players.
The global In-vitro Diagnostic Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The In-vitro Diagnostic Services market presents opportunities for various stakeholders, including Hospitals, Point-Of-Care Testing. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in In-vitro Diagnostic Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global In-vitro Diagnostic Services market was valued at US$ 60800 million in 2023 and is projected to reach US$ 83090 million by 2030, at a CAGR of 4.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the In-vitro Diagnostic Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the In-vitro Diagnostic Services market.
Market Overview: The report provides a comprehensive overview of the In-vitro Diagnostic Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Infectious Testing, Diabetes Testing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the In-vitro Diagnostic Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the In-vitro Diagnostic Services market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the In-vitro Diagnostic Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the In-vitro Diagnostic Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the In-vitro Diagnostic Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the In-vitro Diagnostic Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for In-vitro Diagnostic Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the In-vitro Diagnostic Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- In-vitro Diagnostic Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Infectious Testing
- Diabetes Testing
- Molecular Testing
- Tissue Testing
Market segment by Application
- Hospitals
- Point-Of-Care Testing
- Laborator
- Academic Institutesies
Global In-vitro Diagnostic Services Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- BioRad
- DexCom
- Nova Biomedical
- OraSure
- Pearl Pathways
- Phenomenex
- Qiagen
- Roche Diagnostics
- Siemens
- Sysmex
- Thermofisher
Outline of Major Chapters:
Chapter 1: Introduces the definition of In-vitro Diagnostic Services, market overview.
Chapter 2: Global In-vitro Diagnostic Services market size in revenue.
Chapter 3: Detailed analysis of In-vitro Diagnostic Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In-vitro Diagnostic Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
In-vitro Diagnostic Services Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 60800 million
|
| Forecast Market size by 2030 |
US$ 83090 million
|
| Growth Rate |
CAGR of 4.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 In-vitro Diagnostic Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In-vitro Diagnostic Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In-vitro Diagnostic Services Overall Market Size
2.1 Global In-vitro Diagnostic Services Market Size: 2023 VS 2030
2.2 Global In-vitro Diagnostic Services Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In-vitro Diagnostic Services Players in Global Market
3.2 Top Global In-vitro Diagnostic Services Companies Ranked by Revenue
3.3 Global In-vitro Diagnostic Services Revenue by Companies
3.4 Top 3 and Top 5 In-vitro Diagnostic Services Companies in Global Market, by Revenue in 2023
3.5 Global Companies In-vitro Diagnostic Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-vitro Diagnostic Services Players in Global Market
3.6.1 List of Global Tier 1 In-vitro Diagnostic Services Companies
3.6.2 List of Global Tier 2 and Tier 3 In-vitro Diagnostic Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global In-vitro Diagnostic Services Market Size Markets, 2023 & 2030
4.1.2 Infectious Testing
4.1.3 Diabetes Testing
4.1.4 Molecular Testing
4.1.5 Tissue Testing
4.2 By Type - Global In-vitro Diagnostic Services Revenue & Forecasts
4.2.1 By Type - Global In-vitro Diagnostic Services Revenue, 2019-2024
4.2.2 By Type - Global In-vitro Diagnostic Services Revenue, 2025-2030
4.2.3 By Type - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global In-vitro Diagnostic Services Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Point-Of-Care Testing
5.1.4 Laboratories
5.1.5 Academic Institutes
5.2 By Application - Global In-vitro Diagnostic Services Revenue & Forecasts
5.2.1 By Application - Global In-vitro Diagnostic Services Revenue, 2019-2024
5.2.2 By Application - Global In-vitro Diagnostic Services Revenue, 2025-2030
5.2.3 By Application - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global In-vitro Diagnostic Services Market Size, 2023 & 2030
6.2 By Region - Global In-vitro Diagnostic Services Revenue & Forecasts
6.2.1 By Region - Global In-vitro Diagnostic Services Revenue, 2019-2024
6.2.2 By Region - Global In-vitro Diagnostic Services Revenue, 2025-2030
6.2.3 By Region - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America In-vitro Diagnostic Services Revenue, 2019-2030
6.3.2 US In-vitro Diagnostic Services Market Size, 2019-2030
6.3.3 Canada In-vitro Diagnostic Services Market Size, 2019-2030
6.3.4 Mexico In-vitro Diagnostic Services Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe In-vitro Diagnostic Services Revenue, 2019-2030
6.4.2 Germany In-vitro Diagnostic Services Market Size, 2019-2030
6.4.3 France In-vitro Diagnostic Services Market Size, 2019-2030
6.4.4 U.K. In-vitro Diagnostic Services Market Size, 2019-2030
6.4.5 Italy In-vitro Diagnostic Services Market Size, 2019-2030
6.4.6 Russia In-vitro Diagnostic Services Market Size, 2019-2030
6.4.7 Nordic Countries In-vitro Diagnostic Services Market Size, 2019-2030
6.4.8 Benelux In-vitro Diagnostic Services Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia In-vitro Diagnostic Services Revenue, 2019-2030
6.5.2 China In-vitro Diagnostic Services Market Size, 2019-2030
6.5.3 Japan In-vitro Diagnostic Services Market Size, 2019-2030
6.5.4 South Korea In-vitro Diagnostic Services Market Size, 2019-2030
6.5.5 Southeast Asia In-vitro Diagnostic Services Market Size, 2019-2030
6.5.6 India In-vitro Diagnostic Services Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America In-vitro Diagnostic Services Revenue, 2019-2030
6.6.2 Brazil In-vitro Diagnostic Services Market Size, 2019-2030
6.6.3 Argentina In-vitro Diagnostic Services Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa In-vitro Diagnostic Services Revenue, 2019-2030
6.7.2 Turkey In-vitro Diagnostic Services Market Size, 2019-2030
6.7.3 Israel In-vitro Diagnostic Services Market Size, 2019-2030
6.7.4 Saudi Arabia In-vitro Diagnostic Services Market Size, 2019-2030
6.7.5 UAE In-vitro Diagnostic Services Market Size, 2019-2030
7 In-vitro Diagnostic Services Companies Profiles
7.1 BioRad
7.1.1 BioRad Company Summary
7.1.2 BioRad Business Overview
7.1.3 BioRad In-vitro Diagnostic Services Major Product Offerings
7.1.4 BioRad In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.1.5 BioRad Key News & Latest Developments
7.2 DexCom
7.2.1 DexCom Company Summary
7.2.2 DexCom Business Overview
7.2.3 DexCom In-vitro Diagnostic Services Major Product Offerings
7.2.4 DexCom In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.2.5 DexCom Key News & Latest Developments
7.3 Nova Biomedical
7.3.1 Nova Biomedical Company Summary
7.3.2 Nova Biomedical Business Overview
7.3.3 Nova Biomedical In-vitro Diagnostic Services Major Product Offerings
7.3.4 Nova Biomedical In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.3.5 Nova Biomedical Key News & Latest Developments
7.4 OraSure
7.4.1 OraSure Company Summary
7.4.2 OraSure Business Overview
7.4.3 OraSure In-vitro Diagnostic Services Major Product Offerings
7.4.4 OraSure In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.4.5 OraSure Key News & Latest Developments
7.5 Pearl Pathways
7.5.1 Pearl Pathways Company Summary
7.5.2 Pearl Pathways Business Overview
7.5.3 Pearl Pathways In-vitro Diagnostic Services Major Product Offerings
7.5.4 Pearl Pathways In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.5.5 Pearl Pathways Key News & Latest Developments
7.6 Phenomenex
7.6.1 Phenomenex Company Summary
7.6.2 Phenomenex Business Overview
7.6.3 Phenomenex In-vitro Diagnostic Services Major Product Offerings
7.6.4 Phenomenex In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.6.5 Phenomenex Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen In-vitro Diagnostic Services Major Product Offerings
7.7.4 Qiagen In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.7.5 Qiagen Key News & Latest Developments
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Company Summary
7.8.2 Roche Diagnostics Business Overview
7.8.3 Roche Diagnostics In-vitro Diagnostic Services Major Product Offerings
7.8.4 Roche Diagnostics In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.8.5 Roche Diagnostics Key News & Latest Developments
7.9 Siemens
7.9.1 Siemens Company Summary
7.9.2 Siemens Business Overview
7.9.3 Siemens In-vitro Diagnostic Services Major Product Offerings
7.9.4 Siemens In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.9.5 Siemens Key News & Latest Developments
7.10 Sysmex
7.10.1 Sysmex Company Summary
7.10.2 Sysmex Business Overview
7.10.3 Sysmex In-vitro Diagnostic Services Major Product Offerings
7.10.4 Sysmex In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.10.5 Sysmex Key News & Latest Developments
7.11 Thermofisher
7.11.1 Thermofisher Company Summary
7.11.2 Thermofisher Business Overview
7.11.3 Thermofisher In-vitro Diagnostic Services Major Product Offerings
7.11.4 Thermofisher In-vitro Diagnostic Services Revenue in Global Market (2019-2024)
7.11.5 Thermofisher Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. In-vitro Diagnostic Services Market Opportunities & Trends in Global Market
Table 2. In-vitro Diagnostic Services Market Drivers in Global Market
Table 3. In-vitro Diagnostic Services Market Restraints in Global Market
Table 4. Key Players of In-vitro Diagnostic Services in Global Market
Table 5. Top In-vitro Diagnostic Services Players in Global Market, Ranking by Revenue (2023)
Table 6. Global In-vitro Diagnostic Services Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global In-vitro Diagnostic Services Revenue Share by Companies, 2019-2024
Table 8. Global Companies In-vitro Diagnostic Services Product Type
Table 9. List of Global Tier 1 In-vitro Diagnostic Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In-vitro Diagnostic Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global In-vitro Diagnostic Services Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - In-vitro Diagnostic Services Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - In-vitro Diagnostic Services Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global In-vitro Diagnostic Services Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - In-vitro Diagnostic Services Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - In-vitro Diagnostic Services Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global In-vitro Diagnostic Services Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global In-vitro Diagnostic Services Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global In-vitro Diagnostic Services Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America In-vitro Diagnostic Services Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe In-vitro Diagnostic Services Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia In-vitro Diagnostic Services Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America In-vitro Diagnostic Services Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa In-vitro Diagnostic Services Revenue, (US$, Mn), 2025-2030
Table 30. BioRad Company Summary
Table 31. BioRad In-vitro Diagnostic Services Product Offerings
Table 32. BioRad In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 33. BioRad Key News & Latest Developments
Table 34. DexCom Company Summary
Table 35. DexCom In-vitro Diagnostic Services Product Offerings
Table 36. DexCom In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 37. DexCom Key News & Latest Developments
Table 38. Nova Biomedical Company Summary
Table 39. Nova Biomedical In-vitro Diagnostic Services Product Offerings
Table 40. Nova Biomedical In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 41. Nova Biomedical Key News & Latest Developments
Table 42. OraSure Company Summary
Table 43. OraSure In-vitro Diagnostic Services Product Offerings
Table 44. OraSure In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 45. OraSure Key News & Latest Developments
Table 46. Pearl Pathways Company Summary
Table 47. Pearl Pathways In-vitro Diagnostic Services Product Offerings
Table 48. Pearl Pathways In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 49. Pearl Pathways Key News & Latest Developments
Table 50. Phenomenex Company Summary
Table 51. Phenomenex In-vitro Diagnostic Services Product Offerings
Table 52. Phenomenex In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 53. Phenomenex Key News & Latest Developments
Table 54. Qiagen Company Summary
Table 55. Qiagen In-vitro Diagnostic Services Product Offerings
Table 56. Qiagen In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 57. Qiagen Key News & Latest Developments
Table 58. Roche Diagnostics Company Summary
Table 59. Roche Diagnostics In-vitro Diagnostic Services Product Offerings
Table 60. Roche Diagnostics In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 61. Roche Diagnostics Key News & Latest Developments
Table 62. Siemens Company Summary
Table 63. Siemens In-vitro Diagnostic Services Product Offerings
Table 64. Siemens In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 65. Siemens Key News & Latest Developments
Table 66. Sysmex Company Summary
Table 67. Sysmex In-vitro Diagnostic Services Product Offerings
Table 68. Sysmex In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 69. Sysmex Key News & Latest Developments
Table 70. Thermofisher Company Summary
Table 71. Thermofisher In-vitro Diagnostic Services Product Offerings
Table 72. Thermofisher In-vitro Diagnostic Services Revenue (US$, Mn) & (2019-2024)
Table 73. Thermofisher Key News & Latest Developments
List of Figures
Figure 1. In-vitro Diagnostic Services Segment by Type in 2023
Figure 2. In-vitro Diagnostic Services Segment by Application in 2023
Figure 3. Global In-vitro Diagnostic Services Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global In-vitro Diagnostic Services Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global In-vitro Diagnostic Services Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In-vitro Diagnostic Services Revenue in 2023
Figure 8. By Type - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 9. By Application - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 10. By Type - Global In-vitro Diagnostic Services Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 12. By Application - Global In-vitro Diagnostic Services Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 14. By Region - Global In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 15. By Country - North America In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 16. US In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 17. Canada In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 20. Germany In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 21. France In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 23. Italy In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 24. Russia In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 28. China In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 29. Japan In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 32. India In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 34. Brazil In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa In-vitro Diagnostic Services Revenue Market Share, 2019-2030
Figure 37. Turkey In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 38. Israel In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 40. UAE In-vitro Diagnostic Services Revenue, (US$, Mn), 2019-2030
Figure 41. BioRad In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. DexCom In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Nova Biomedical In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. OraSure In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pearl Pathways In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Phenomenex In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Qiagen In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Roche Diagnostics In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Siemens In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Sysmex In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Thermofisher In-vitro Diagnostic Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
